INNOVIO QoQ revenues down for the period ended June 30, 2021
Company working on COVID vaccine INO 4800
Company working on COVID vaccine INO 4800
The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Board declares interim dividend of Rs 2 per equity share
Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease
Board approves fundraise of Rs 1500 crore
PAT rises to Rs 195.76 crore
India business contributes to a stellar performance
Forex gains stood at Rs 20 crore for the quarter
Subscribe To Our Newsletter & Stay Updated